StonvexLoading…
StonvexStonvexStonvexCore line items from CPB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-08-03 | Annual 2024 2024-07-28 | Annual 2023 2023-07-30 | Annual 2022 2022-07-31 |
|---|---|---|---|---|
Revenue | $10.25B | $9.64B | $9.36B | $8.56B |
Operating Income | $1.12B | $1.00B | $1.31B | $1.16B |
Net Income | $602.00M | $567.00M | $858.00M | $757.00M |
EPS (Diluted) | $2.01 | $1.89 | $2.85 | $2.51 |
Total Assets | $14.90B | $15.23B | $12.06B | $11.89B |
Total Liabilities | $10.99B | $11.44B | $8.39B | $8.56B |
Cash & Equivalents | $132.00M | $108.00M | $189.00M | $109.00M |
Free Cash Flow OCF − CapEx | $705.00M | $668.00M | $773.00M | $939.00M |
Shares Outstanding | 300.00M | 300.00M | 301.00M | 302.00M |